跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZARELIS RETARD 225 MG COMPRIMIDOS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ZARELIS RETARD 225 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Approved
STANDARD
ZARELIS RETARD 225 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Itf Hellas S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 19, 2023
Approval ID
b820b9dedb15e4f1
Company
Itf Hellas S.A.
Type
Standard
Approval Details
Approval Id
b820b9dedb15e4f1
Drug Cima Aemps Name
ZARELIS RETARD 225 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Register Number
68911-11-9-2013IP4
Holder Company Name
Itf Hellas S.A.
Marketing Company Name
Melyfarma S.L.
Authorization Date
2023-12-19
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
225 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Itf Hellas S.A.
Active Ingredients
VENLAFAXINA HIDROCLORURO
254,58 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 19, 2023
Approval ID
b820b9dedb15e4f1
Type
Standard
Back to CIMA-AEMPS Approvals